The intracellular antibody capture technology (IACT): Towards a consensus sequence for intracellular antibodies

Journal of Molecular Biology

Volumn 317, Issue 1, 2002, Pages 73-83

  Visintin, Michela ^a,b   Settanni, Giovanni ^a   Maritan, Amos ^a   Graziosi, Sergio ^a   Marks, James D ^c   Cattaneo, Antonino ^a,b  

^a SISSA   (Italy)

^b Lay Line Genomics SpA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Functional genomics; Intrabodies; Single chain Fv; TAU

Indexed keywords

AMINO ACID; ANTIBODY; CELL PROTEIN; EPITOPE; TAU PROTEIN;

ALZHEIMER DISEASE; ANTIBODY ISOLATION; ARTICLE; BIOTECHNOLOGY; CELL; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG ISOLATION; EPITOPE MAPPING; HUMAN; IN VIVO STUDY; MICROTUBULE; NERVE CELL LESION; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS;

EID: 0036299049     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2002.5392     Document Type: Article

References (63)

1. Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens
2. The protein-protein interaction map of Helicobacter pylori
3. A network of protein-protein interactions in yeast
4. Genomic biology
5. Oxidized redox state of glutathione in the endoplasmic reticulum
6. Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria
7. Expression of an antibody fragment at high levels in the bacterial cytoplasm
8. A natural antibody missing a cysteine in VH: Consequences for thermodynamic stability and folding
9. Antibody scFv fragments without disulfide bonds made by molecular evolution
10. Selection of antibodies for intracellular function using a two-hybrid in vivo system
11. In vivo selection of single-chain antibodies using a yeast two-hybrid system
12. Analysis of the interaction between single-chain variable fragments and their antigen in a reducing intracellular environment using the two-hybrid system
13. Building antibodies from their genes
14. Bypassing immunization: Building high affinity human antibodies by chain shuffling
15. Selection for improved protein stability by phage display
16. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: Improved in vivo folding and physical characterization of an engineered scFv fragment
17. Antibodies from Escherichia coli
18. Reproducing the natural evolution of protein structural features with the selectively infective phage (SIP) technology. The kink in the first strand of antibody kappa domains
19. A novel genetic system to detect protein-protein interactions
20. Tau protein and neurofibrillary pathology of Alzheimer's disease
21. Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens
22. Selecting intracellular antibodies using the two-hybrid system
23. The neuronal microtubule-associated protein Tau is a substrate for caspase-3 and an effector of apoptosis
24. Different equilibrium stability behavior of ScFv fragments: Identification, classification, and improvement by protein engineering
25. The selection of intracellular antibodies
26. Targeting vectors for intracellular immunisation
27. Expression and targeting of intracellular antibodies in mammalian cells
28. In vivo expression of anti-tau intrabodies selected by the Intrabody Trap Technology (ITT)
29. Accessing the Kabat antibody sequence database by computer
30. SUBIM: A program for analysing the Kabat database and determining the variability subgroup of a new immunoglobulin sequence
31. Intracellular antibody-caspase-mediated cell killing: An approach for application in cancer therapy
32. Stable onestep technetium-99 m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex
33. Direct selection of antibodies that coordinate metals from semisynthetic combinatorial libraries
34. Characterisation of an antibody relevant to the neuropathology of Alzheimer disease
35. Recombinant antibodies: A novel approach to cancer diagnosis and therapy
36. Intrabody construction and expression III: Engineering hyperstable V(H) domains
37. Antigen sequence- and library-based mapping of linear and discontinuous protein-protein-interaction sites by spot synthesis
38. Epitope mapping of a protein using the Geysen (PEPSCAN) procedure
39. Molecular technology: Peptide epitope mapping and the pin technology
40. Libraries of peptides and proteins displayed on filamentous phage
41. Use of living columns to select specific phage antibodies
42. "In vitro evolution" of ligands for HCV-specific serum antibodies
43. "Affinity maturation" of ligands for HCV-specific serum antibodies
44. Making antibodies by phage display technology
45. Antibody arrays for high-throughput screening of antibody-antigen interactions
46. By-passing selection: Direct screening for antibody-antigen interactions using protein arrays
47. Overexpression of Alzheimer's PHF core tau fragments: Implications for the tau truncation hypothesis
48. Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein
49. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein
50. Maltose-binding protein from Escherichia coli
51. Quick purification of recombinant human truncated tau proteins for immunoanalysis
52. Exploiting recombination in single bacteria to make large phage antibody libraries
53. Mammalian Ras interacts directly with the serine/threonine kinase Raf
54. Identification of a new family of tissue -specific basic helix-loop-helix proteins with a two-hybrid system
55. Improved method for high efficiency transformation of intact yeast cells
56. DMSO-enhanced whole cell yeast transformation
57. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier
58. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51
59. Isolation of monoclonal antibodies specific for human c-myc proto- oncogene product
60. Kabat database and its applications: 30 years after the first variability plot
61. Canonical structures for the hypervariable regions of immunoglobulins